Lista de obras -

ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group

artículo científico publicado en 2015

Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials

artículo científico publicado en 2012

All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study

artículo científico publicado en 2016

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

artículo científico publicado en 2009

Colorectal cancer in the elderly: is palliative chemotherapy of value?

artículo científico publicado en 2003

Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?

artículo científico publicado en 2005

Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

artículo científico publicado en 2007

Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting

artículo científico publicado en 2005

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

artículo científico publicado en 2016

Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials

artículo científico publicado en 2007

Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group

artículo científico publicado en 2008

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

artículo científico publicado en 2007

Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks

artículo científico publicado en 2007

Never too old? Age should not be a barrier to enrollment in cancer clinical trials

artículo científico publicado en 2005

Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin

artículo científico publicado en 2012

Role of new agents in the treatment of colorectal cancer

artículo científico publicado en 2004

Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study ⬇️

artículo científico publicado el 29 de septiembre de 2012

TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group ⬇️

artículo científico publicado el 19 de marzo de 2012

The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines

artículo científico publicado en 2002

The role of new agents in the treatment of colorectal cancer

artículo científico publicado en 2004

Towards a pan-European consensus on the treatment of patients with colorectal liver metastases

artículo científico publicado en 2006

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

artículo científico publicado en 2009

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients

artículo científico publicado en 2014

Lista de obras de

ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group

Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials

All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Colorectal cancer in the elderly: is palliative chemotherapy of value?

Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?

Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials

Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks

Never too old? Age should not be a barrier to enrollment in cancer clinical trials

Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin

Role of new agents in the treatment of colorectal cancer

Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study ⬇️

TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group ⬇️

The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines

The role of new agents in the treatment of colorectal cancer

Towards a pan-European consensus on the treatment of patients with colorectal liver metastases

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients